Bristol-Myers Squibb Company
Exchange: NYSESector: HealthcareIndustry: Drug Manufacturers - General
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
Did you know?
Capital expenditures increased by 5% from FY24 to FY25.
Current Price
$58.22
-3.91%GoodMoat Value
$98.93
69.9% undervaluedProfile
Valuation (TTM)
Market Cap$118.56B
P/E16.30
EV$150.48B
P/B6.42
Shares Out2.04B
P/Sales2.45
Revenue$48.48B
EV/EBITDA11.56
Bristol-Myers Squibb Company (BMY) Stock News
BMY Stock News & Headlines
Latest stock news and headlines for Bristol-Myers Squibb Company (BMY). Stay informed on earnings reports, analyst upgrades and downgrades, market-moving events, and company announcements.
Current stock price: $58.22. Market cap: $118.56B. Sector: Healthcare. Industry: Drug Manufacturers - General. This page aggregates the latest news articles relevant to BMY from financial news sources, helping investors stay current on events that may impact Bristol-Myers Squibb Company's stock price.
News catalysts can drive significant short-term price movement. Earnings surprises, management changes, product launches, regulatory decisions, and analyst coverage changes all create opportunities and risks. Combine news monitoring with GoodMoat's fundamental analysis, quality scores, and valuation tools for a complete research workflow on Bristol-Myers Squibb Company (BMY).